Inborn Errors of Metabolism Referrals- Shahid Sadoughi Hospital: A Cross- Sectional Study

Document Type : Original Article

Authors

1 Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Science, Yazd, Iran

2 Department of Pediatrics, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

3 Mother and Newborn Health Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

4 Nutrition and Food Security Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

5 Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

6 Hematology and Oncology Research Center, Shahid Sadoughi University of Medical Science, Yazd, Iran

7 Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

8 Clinical Research Development Center of Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Abstract

Background: Inborn Errors of Metabolism (IEMs) are a group of heterogeneous disorders resulting from absent or decreased metabolic pathway activity. They are typically rare, but are more common in consanguineous population.
Methods: In this cross sectional study, all children with symptoms suspicious for IEMs who referred to Shahid Sadoughi Hospital in Yazd during a 5-year period (2013-2018) were investigated for metabolic diseases. The diagnoses were further confirmed by clinical symptoms and biochemical analysis. IEMs type, age of diagnosis, family history and disease outcome were recorded.
Results: In this study, 39 symptomatic children with a median age of
48 months were diagnosed with different types of metabolic diseases. About 64.1% of the patients were born from consanguineous marriage. The patients’ mean age at the time of diagnosis was 25.3 ± 5.1 months. The most frequent disorders were organic acidemias which were found in 12 patients (30.8%), lysosomal storage disorders which were found in 8 patients (20.5%), and amino acid disorders excluding phenylketonuria which was found in 8 patients (20.5%). Most of the patients (60%) were diagnosed before the age of 6 months. Mortality from metabolic disorders was 5 (12.8%). The rest of the patients (22 cases, 56.4 %) had developmental delay.
Conclusion: It was found that the prevalence of inherited metabolic disorders was higher in countries with a high prevalence of consanguineous marriage, such as Iran. More extensive newborn screening is needed for ensuring early diagnosis of these patients given that delay in diagnosis of this disorder may be associated with high morbidity and mortality.

Keywords

References

  1.  

    1. Sutton VR. Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features. [Online]. [cited 2022 Jan 8]; Available from: URL:

    https://www.uptodate.com/contents/inborn-errors-of-metabolism-epidemiology-pathogenesis-and-clinical-features

    1. Golbahar J, Karamizadeh Z, Honardar Z. Selective screening of amino acid disorders in the south-west of Iran, Shiraz. J Inherit Metab Dis 2002; 25(6): 519-21.
    2. Alijanpour Aghamaleki M, Esmaeili Dooki MR, Zahed PashaY, Moslemi L. The frequency of hereditary metabolic diseases in children referred to Amirkola Children Hospital (2005-2015). JBUMS 2016; 18(10): 60-4. [In Persian].
    3. Wilcken B, Wiley V, Hammond J, Carpenter K. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 2003; 348(23): 2304-12.
    4. Dionisi-Vici C, Rizzo C, Burlina AB, Caruso U, Sabetta G, Uziel G, et al. Inborn errors of metabolism in the Italian pediatric population: a national retrospective survey. J Pediatr 2002; 140(3): 321-7.
    5. Sanderson S, Green A, Preece MA, Burton H. The incidence of inherited metabolic disorders in the West Midlands, UK. Arch Dis Child 2006; 91(11): 896-9.
    6. Hassan FA, El-Mougy F, Sharaf SA, Mandour I, Morgan MF, Selim LA, et al. Inborn errors of metabolism detectable by tandem mass spectrometry in Egypt: The first newborn screening pilot study. J Med Screen 2016; 23(3): 124-9.
    7. Karam PE, Habbal MZ, Mikati MA, Zaatari GE, Cortas NK, Daher RT. Diagnostic challenges of aminoacidopathies and organic acidemias in a developing country: a twelve-year experience. Clin Biochem 2013; 46(18): 1787-92.
    8. Alfadhel M, Benmeakel M, Hossain MA, Al Mutairi F, Al Othaim A, Alfares AA, et al. Thirteen year retrospective review of the spectrum of inborn errors of metabolism presenting in a tertiary center in Saudi Arabia. Orphanet J Rare Dis 2016; 11(1): 126.
    9. Huang X, Yang L, Tong F, Yang R, Zhao Z. Screening for inborn errors of metabolism in high-risk children: a 3-year pilot study in Zhejiang Province, China. BMC Pediatr 2012; 12: 18.
    10. Arif H, Thejeal RF, Farhan A. Inborn errors of metabolism status in Iraq. Artic IOSR J Pharm Biol Sci 2016; 11(2): 58-62.
    11. Shafeghati Y, Kariminejad R, Azimi F, Kariminejad MH, Kleijer WJ, Van Digglen OP. Epidemiology and relative incidence of rare neurometabolic and neurogenetic disorders in Arch Irn Med 2001; 4(2): 67-71. [In Persian].
    12. Saadallah AA, Rashed MS. Newborn screening: experiences in the Middle East and North Africa. J Inherit Metab Dis; 30(4): 482-9.
    13. AlObaidy H. Patterns of inborn errors of metabolism: A 12 year single-center hospital-based study in Libya. Qatar Med J 2013; (2): 57-65.
    14. Olpin SE. The metabolic investigation of sudden infant death. Ann Clin Biochem 2004; 41(Pt 4): 282-93.
    15. Sherazi NA, Habib Khan A, Jafri L, Jamil A, Ali Khan N, Afroze B. Selective screening for organic acidurias and amino acidopathies in Pakistani Children. J Coll Physicians Surg Pak 2017; 27(4): 218-21.
    16. Pishva N, Mirzaee A, Karamizade Z, Pourarian S, Hemmati F, Razvi M, et al. Selective screening of high-risk Iranian patients for the detection of inborn error of metabolism. IJN 2015; 5(4): 11-4.
    17. Najafi R, Hashemipour M, Mostofizadeh N, Ghazavi M, Nasiri J, Shahsanai A, et al. Demographic and clinical findings in pediatric patients affected by organic acidemia. Iran J Child Neurol 2016; 10(2): 74-81.
    18. Narayanan MP, Kannan V, Vinayan KP, Vasudevan DM. Diagnosis of major organic acidurias in children: two years experience at a tertiary care centre. Indian J Clin Biochem 2011; 26(4): 347-53.
    19. Muranjan MN, Kondurkar P. Clinical features of organic acidemias: experience at a tertiary care center in Mumbai. Indian Pediatr 2001; 38(5): 518-24.
    20. Dogan E, Uysal S, Ozturk Y, Arslan N, Coker C. Selective screening for inborn errors of metabolism: A report of six years experience. Iran J Pediatr 2017; 27(5): e11323.
    21. Frazier DM, Millington DS, McCandless SE, Koeberl DD, Weavil SD, Chaing SH, et al. The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005. J Inherit Metab Dis 2006; 29(1): 76-85.
    22. Khalaf SM, El-Tellawy MM, Refat NH, El-Aal AMA. Detection of some metabolic disorders in suspected neonates admitted at Assiut University Children Hospital. Egypt J Med Hum Genet 2019; 20(1): 1-7.
    23. Selim LA, Hassan SAH, Salem F, Orabi A, Hassan FA, El-Mougy F, et al. Selective screening for inborn errors of metabolism by tandem mass spectrometry in Egyptian children: A 5 year report. Clin Biochem 2014; 47(9): 823-8.
    24. Han LS, Ye J, Qiu WJ, Gao XL, Wang Y, Gu XF. Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report. J Inherit Metab Dis 2007; 30(4): 507-14.
    25. Cheema HA, Malik HS, Parkash A, Fayyaz Z. Spectrum of Inherited Metabolic Disorders in Pakistani Children Presenting at a Tertiary Care Centree. J Coll Physicians Surg Pakistan 2016; 26(6): 498-502.
    26. Song YZ, Li BX, Hao H, Xin RL, Zhang T, Zhang CH, et al. Selective screening for inborn errors of metabolism and secondary methylmalonic aciduria in pregnancy at high risk district of neural tube defects: a human metabolome study by GC-MS in China. Clin Biochem 2008; 41(7-8): 616-20.
    27. Satwani H, Raza J, Hanai J, Nomachi S. Prevalence of selected disorders of inborn errors of metabolism in suspected cases at a Tertiary Care Hospital in Karachi. J Pak Med Assoc 2009; 59(12): 815-9.
    28. Sun W, Wang Y, Yang Y, Wang J, Cao Y, Luo F, et al. The screening of inborn errors of metabolism in sick Chinese infants by tandem mass spectrometry and gas chromatography/mass spectrometry. Clin Chim Acta 2011; 412(13-14): 1270-4.
    29. Qiu WJ, Gu XF, Ye J, Han LS, Bai HT, Wang X, et al. Clinical and mutational study of a Chinese infant with isovaleric acidemia. Zhonghua Er Ke Za Zhi 2008; 46(7): 526-30. [In Chinese].
    30. Niu DM, Chien YH, Chiang CC, Ho HC, Hwu WL, Kao SM, et al. Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan. J Inherit Metab Dis 2010; 33(Suppl 2): S295-305.
    31. Fateen EM, Gouda AS, Ibrahim MM, Abdallah ZY. Fifteen years experience: Egyptian metabolic lab. Egypt J Med Hum Genet 2014; 15(4): 379-85.
World Journal of Peri and Neonatology
Volume 4, Issue 2
December 2021
Pages 82-87

Files

History

  • Receive Date: 16 February 2022
  • Accept Date: 16 February 2022
  • First Publish Date: 16 February 2022

Share

How to cite

Statistics